O-004 - Effects of nal-IRI (MM-398) +/- 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: results from NAPOLI-1.
Authors
Hubner, Richard ACubillo, A
Blanc, J
Melisi, D
Von Hoff, D
Wang-Gillam, A
Chen, L
Becker, C
Mamlouk, K
Belanger, B
Yang, Y
de Jong, F
Siveke, J
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2016-06
Metadata
Show full item recordCitation
O-004 - Effects of nal-IRI (MM-398) +/- 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: results from NAPOLI-1. 2016, 27(suppl 2):ii119 Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw198.04Additional Links
https://academic.oup.com/annonc/article/2475056/O-004<breakType
Meetings and ProceedingsLanguage
enISSN
1569-80410923-7534
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw198.04